Coronavirus - we're here to help
From how to access your account online, scam awareness, your wellbeing and our community we're here to help.

Skip to main content
  • Register
  • Help
  • Contact us
  • Log in to HL Account

Johnson and Johnson's Covid-19 vaccine approval possible in March

Wed 13 January 2021 21:36 | A A A

No recommendation

No news or research item is a personal recommendation to deal. Hargreaves Lansdown may not share ShareCast's (powered by Digital Look) views.

(Sharecast News) - Emergency Use Approval for Johnson&Johnson's Covid-19 vaccine may not arrive before March, potentially a few weeks later than had been hoped for.

However, the first batch of late-stage clinical trial data is expected in the last week of January or the first week of February, the drug giant's Chief Scientific Officer, Paul Stoffels, told Bloomberg in an interview.

Officials from the US government's Operation Warp Speed are on record predicting that EUA might arrive in the middle of February, but that timeline might prove to aggressive given J&J's own guidance, the newswire added.

Stoffels reportedly added: "We hope and trust that somewhere in March, we may get that approval."

    The value of investments can go down in value as well as up, so you could get back less than you invest. It is therefore important that you understand the risks and commitments. This website is not personal advice based on your circumstances. So you can make informed decisions for yourself we aim to provide you with the best information, best service and best prices. If you are unsure about the suitability of an investment please contact us for advice.

    More company news from ShareCast